Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma

Minna Taskinen,Riku Louhimo,Satu Koivula,Ping Chen,Ville Rantanen,Harald Holte,Jan Delabie,Marja-Liisa Karjalainen-Lindsberg,Magnus Björkholm,Øystein Fluge,Lars Møller Pedersen,Karin Fjordén,Mats Jerkeman,Mikael Eriksson,Sampsa Hautaniemi,Sirpa Leppä

Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma

2014

Minna Taskinen
Riku Louhimo
Satu Koivula
Ping Chen
Ville Rantanen
Harald Holte
Jan Delabie
Marja-Liisa Karjalainen-Lindsberg
Magnus Björkholm
Øystein Fluge
Lars Møller Pedersen
Karin Fjordén
Mats Jerkeman
Mikael Eriksson
Sampsa Hautaniemi
Sirpa Leppä

Despite improved survival for the patients with diffuse large B-cell lymphoma (DLBCL), the prognosis after relapse is poor. The aim was to identify molecular events that contribute to relapse and treatment resistance in DLBCL.

Keywords:

Oncology
Prospective cohort study
Diffuse large B-cell lymphoma
Lymphoma
Immunotherapy
Young adult
Pathology
Medicine
Internal medicine
improved survival
poor prognosis
treatment resistance

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations